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Abstract
Background: Modifications on specific histone residues and DNA methylation play an essential role in lineage choice and
cellular reprogramming. We have previously shown that histone modifications or combinatorial codes of transcription
factors (TFs) are critical for the differentiation of multipotential progenitors into myelinating oligodendrocytes. In this study
we asked whether combining global manipulation of DNA methylation and histone acetylation together with the
expression of oligodendrocyte- specific TFs, was sufficient to switch the identity of fibroblasts into myelin gene-expressing
cells.
Methodology/Principal Findings: Transfection of six oligodendrocyte-specific TFs (Olig1, Olig2, Sox10, Mash1, E47 and
Nkx2.2) into NIH3T3 fibroblasts was capable of inducing expression of myelin gene promoter-driven reporters, but did not
activate endogenous myelin gene expression. These results suggested the existence of a transcriptionally incompetent
chromatin conformation in NIH3T3 fibroblasts. Using chromatin immunoprecipitation (ChIP) analysis, we compared the
histone code on the conserved regions of myelin genes (i.e. Mbp and Mag) in differentiating oligodendrocyte progenitors
and NIH3T3 fibroblasts. Chromatin at myelin gene loci was characterized by the presence of repressive histone
modifications (me3K9H3 and me3K27H3) in NIH3T3 fibroblasts and active histone marks (me3K4H3 and AcH3) in
oligodendrocyte lineage cells. To induce a transcriptionally competent chromatin signature, NIH3T3 fibroblasts were treated
with 5-azadeoxy-citidine (5-AzaC) to decrease DNA methylation, and trichostatin A (TSA) or sirtinol, to favor histone
acetylation. Treatment with 5-AzaC/TSA but not sirtinol, resulted in the detection of endogenous myelin gene transcripts in
fibroblasts, although not to the levels detected in myelinating cells. Transfection of oligodendrocyte-specific TFs after 5-
AzaC/TSA treatment did not further increase myelin gene expression, nor did it reprogram the transcriptional network of
NIH3T3 fibroblasts into that of oligodendrocytes.
Conclusions/Significance: These results suggest that reprogramming of fibroblasts into myelin gene-expressing cells not
only requires transcriptional activation, but also chromatin manipulations that go beyond histone acetylation and DNA
methylation.
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Introduction
Epigenetic gene regulation plays an important role in the
control of cell proliferation, specification and differentiation [1,2].
Recent studies have shown that treatment with inhibitors of
histone deacetylases (Hdacs), histone methyltransferases and/or
DNA methyltransferases favor the efficiency of reprogramming
somatic fibroblasts into induced pluripotent stem (iPS) cells [3,4,5]
or neural-like cells [6,7]. However, it is unclear if a non-
myelinating cell (e.g. NIH3T3 fibroblasts) can be directly
reprogrammed into a myelin-gene expressing cell by global
epigenetic manipulation.
The specific modifications on individual histone amino acid
residues determine the accessibility of chromatin, thereby affecting
gene expression [1]. The balance of active and repressive histone
modifications results in the establishment of a ‘‘histone code’’,
which together with DNA methylation, determines the specific
lineage choice and defines the differentiation stage of a cell.
Oligodendrocytes are the myelin forming cells in the central
nervous system. They derive from multipotential progenitors that
develop into mature cells through a complex interplay between
cell specific transcription factors (TFs) and epigenetic modulators,
including microRNAs, histone modifiers and DNA methylation
[8,9]. Several studies have reported a critical role of histone
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development and repair [10,11,12,13]. Histone deacetylation is
one of the first characterized modifications and is typically
associated with gene repression [1,2] We have previously shown
that histone deacetylation, mediated by Hdacs decreases the
expression of transcriptional regulators, such as Id4 and Tcf7l2,
effectively relieving the inhibition on myelin gene expression
during oligodendrocyte development [10,11,12]. In animal models
of demyelinating diseases pharmacological inhibition of Hdac or
inefficient recruitment to the promoters of these genes, due to
aging, resulted in high levels transcriptional inhibitors and
inefficient remyelination [11]. Microinjections of antisense hdac1
oligonucleotides successfully prevented differentiation of oligoden-
drocytes in zebrafish [14] and targeted deletion of Hdac1 and
Hdac2 in mice did not allow proper formation of myelin during
early postnatal life [15]. In addition, Hdac11 was previously
reported to facilitate Myelin basic protein (Mbp) and Proteolipid Protein
(Plp) gene expression, although the molecular mechanisms remain
not completely understood [16].
Several elegant studies have addressed the role of lineage-
specific transcription factors in oligodendrocyte lineage progres-
sion (reviewed in [17]) and supported their identification with
genetic animal models. However, transfection of combinations of
oligodendrocyte-specific TFs in unrelated cell lineages (i.e.
fibroblasts) was sufficient to activate the expression of luciferase
reporters driven by myelin gene promoters [18], but unable to
activate endogenous myelin gene expression. We reasoned that
these differences must be consequent to specific chromatin
landscapes characteristic of each cell type and this was the
premise for the current study.
In this study, we first defined the histone code on conserved
regions of myelin genes in progenitors and differentiated primary
oligodendrocytes and then compared the results with those
obtained in myelinating cell lines (i.e. Olineu cells) or in fibroblast
cells (NIH3T3). We then postulated that global manipulations of
the histone code using chromatin modifying agents could change
the cell-specific chromatin conformation of fibroblasts and render
it more prone to activation by transfected oligodendrocyte-specific
TFs. To test this hypothesis, we treated fibroblasts with the DNA
demethylating agent 5-AzaC and either the Hdac inhibitor TSA
or the sirtuin inhibitor sirtinol and then transfected fibroblasts with
six oligodendrocyte-specific TFs (Olig1, Olig2, Mash1, Sox10, Nkx2.2
and E47). Although treatment of 5-AzaC and TSA enhanced
transcription of endogenous myelin genes in fibroblasts, the
additional over-expression of cell specific transcriptional regulators
did not further enhance myelin gene transcript levels. These
findings suggest that global epigenetic modifications are necessary,
but not sufficient to trans-differentiate fibroblasts into oligoden-
drocytes, and underscore the importance of chromatin compac-
tion and the associated repression of inhibitory events for the
differentiation of myelinating cells.
Results
Oligodendrocyte-specific transcription factors fail to
activate endogenous myelin gene expression in
fibroblasts
In this study, we first analyzed the levels of Mbp, Myelin associated
glycoprotein (Mag) and Myelin oligodendrocyte glycoprotein (Mog) tran-
scripts as a measure of the differentiation of primary oligoden-
drocyte progenitor cells (OPCs) into mature oligodendrocytes
(Fig. 1A). Mbp is one of the most abundant proteins in myelin of
the central nervous system (CNS) and is required for the formation
of a compact structure [19]. Mag is the protein that is in contact
with the axon, while Mog is one of the latest genes to be
transcribed during differentiation and encodes for a protein that is
required for myelin maintenance [19]. As expected, analysis of
RNA samples by quantitative RT-PCR showed increased myelin
gene transcripts as OPCs were kept for one to five days in
differentiation conditions in vitro. This pattern was then compared
with the one obtained in the immortalized oligodendrocyte
progenitor cell line Olineu [20] after differentiation and with the
endogenous levels of these myelin gene transcripts in the fibroblast
cell line, NIH3T3 (Fig. 1B). Myelin genes were not detected in
fibroblasts, but were expressed in Olineu, although the temporal
increase was not as robust as the one detected in primary cells
(Figure 1B). As expected, fibroblasts expressed very low levels of
transcriptional activators (Olig1, Olig2, Sox10 and Mash1), in the
order of hundreds or thousands fold lower than Olineu and higher
levels of transcriptional inhibitors (Id4) (Figure 1C). A potential
explanation for the lack of myelin expression in fibroblasts
therefore could be the absence of a threshold level of transcrip-
tional activators to overcome the negative effect of the transcrip-
tional inhibitors. Indeed, we had previously shown that overex-
pression of oligodendrocyte-specific transcription factors (Olig1,
Olig2, Sox10, E47, Mash1, and Nkx2.2) in NIH3T3 cells was
sufficient to transiently activate exogenous luciferase reporters
driven by the Mbp promoters [18]. We therefore attempted to
artificially increase the levels of the oligodendrocyte-specific TFs
by transfecting them into NIH3T3. However, the over-expressing
cells failed to show increased endogenous myelin gene expression
(Figure 1D and 1E). Thus, the transfection of combination of
oligodendrocyte-specific transcriptional activators was sufficient to
drive the expression of exogenously added Mbp promoter-driven
reporters, but was not sufficient to drive endogenous expression of
myelin genes. The discordance of these two results suggested that
the accessibility of TFs to endogenous myelin genes in fibroblasts
might be compromised, due to a non-permissive chromatin
environment that is present in NIH3T3 cells.
Specific patterns of histone code in myelinating and non-
myelinating cells
It is well accepted that the accessibility of chromatin to
transcription factors is dependent on post-translational modifica-
tion of histones that determine the conformational state of
chromatin. For this reason, we sought to define the ‘‘histone
code’’ of myelin gene loci in NIH3T3 fibroblasts and compared it
with that detected in myelinating cell lines (i.e. Olineu cells) and in
undifferentiated OPCs and mature oligodendrocytes. We focused
our analysis on highly conserved regions in the myelin genes (Mbp
and Mag) with the assumption that these conserved elements play
important regulatory functions. To identify highly conserved
regions in Mbp, we used the NCSRS software [21] and performed
multiple sequence alignments of homologous sequences using the
rat genome as a baseline. These alignments identified one
conserved region in the proximal promoter of Mbp (close to the
transcription start site), two conserved regions further 59 upstream
(CR1 and CR2) and one conserved region in the 39 transcript
region (CR3) (Figure 2A and 2B). The conserved modules
identified within the Mbp promoter and upstream sequence
contain the four regulatory regions, previously identified using
transgenic approaches in vivo [22]. In particular, CR2, which
coincides with the M3 element, corresponds to a conserved region
that confers high levels of expression in oligodendrocytes in the
CNS [22]. For this reason we focused our analysis on the
characterization of the histone code at the CR2 and the proximal
promoter region.
Histone Code of Myelin Genes
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accessibility of transcription factors to myelin gene loci, was then
studied using chromatin immunoprecipitation (ChIP) with anti-
bodies against histone marks associated with transcriptional
activity (i.e. trimethylated lysine 4 on histone 3 (me3K4H3) and
pan acetylated H3 (AcH3)) as well as those associated with
transcriptional repression (i.e. trimethylated lysine 9 on histone 3
(me3K9H3) and trimethylated lysine 27 on histone 3
Figure 1. Transfection of oligodendrocyte-specific transcription factors is not sufficient to express endogenous myelin genes in
fibroblasts. Temporal pattern of regulation of myelin gene expression in rat primary oligodendrocyte progenitors during differentiation (A).
Transcript levels of Mbp, Mag and Mog were analyzed by quantitative RT-PCR in rat primary progenitors and in differentiated cells at the indicated
time points (1, 3 and 5 days). Transcript levels of myelin genes (B) and oligodendrocyte-specific transcription factors (C) were analyzed by qRT-PCR in
non-myelinating (NIH3T3) and in myelinating (Olineu) cell lines differentiated with cAMP for multiple time points (DIV 0,1,3,5,7). The effect of
transfecting combinations of positive transcription factors (E47, Mash1, Nkx2.2, Sox10, Olig1 and Olig2) was assessed by detecting myelin gene
transcripts using qRT-PCR (D) and myelin proteins, using immunocytochemistry (E). Values were normalized by the levels of Gapdh and shown as
relative to the levels detected in untreated sample. The bar graphs represent the average values and error bars represent standard deviations (n=3;
*p ,0.05; ** p,0.01; *** p,0.001).
doi:10.1371/journal.pone.0013023.g001
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PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e13023Figure 2. Comparison of the chromatin regions at the Mbp locus between oligodendrocyte progenitors and fibroblasts. Comparative
sequence analysis of conserved (pink) and transcribed (blue) regions of the Mbp promoter in different animal species (A). Schematic representation of
conserved regulatory regions (blue boxes) of the Mbp promoter (B). Comparative ChIP analysis of samples isolated from NIH3T3, Olineu cells (Oli),
proliferating (OPC) and differentiating (OPC diff) oligodendrocyte progenitors (C). Histone modifications in the different Mbp promoter regions were
assessed by immunoprecipitating chromatin with antibodies specific for the activating histone marks (me3K4H3 and AcH3) (C) or for repressive
histone modifications (me3K9H3 and me3K27H3) (D). The Mbp locus was characterized by permissive histone marks in oligodendrocyte progenitors
and non-permissive marks in fibroblasts. ChIP was performed on five separate cultures. Results are expressed as mean 6 standard deviation (SD) and
statistically analyzed using two tailed Student’s t tests (*p,0.05, **p,0.01).
doi:10.1371/journal.pone.0013023.g002
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differentiated primary oligodendrocyte cultures and the experi-
ment was repeated five times on freshly prepared samples. After
immunoprecipitation with the antibodies, the conserved regions of
the Mbp locus were analyzed.
The chromatin regions corresponding to the promoter and
conserved upstream regulatory regions of the Mbp locus were
characterized by the presence of both active (me3K4H3 and
AcH3) and repressive (me3K9H3 and me3K27H3) marks in
undifferentiated primary OPCS(Fig. 2C–D). The presence of both
marks of activation (me3K4H3) and repression (me3K27H3) has
also been defined as ‘‘bivalent mark’’ [23,24] and has been
reported to characterize a state of transcriptional competence. As
OPCs differentiate into oligodendrocytes, there is a resolution of
the bivalent marks at the CR2 and proximal promoter regions.
The chromatin at these regions is characterized by decreased
me3K27H3 and increased me3K4H3 and to a lower extent
increased panAcH3 (Fig. 2C–D). This histone code is consistent
with the expression of Mbp transcripts during this transition
(Figure 1A). Therefore, the expression of Mbp during the
differentiation of primary OPCs into oligodendrocytes is charac-
terized by the deposition of active methylation marks on lysine 4
and removal of repressive methylation marks on lysine 27 of
histone H3 in chromatin at the highly conserved regions of the
Mbp locus.
We then asked whether the chromatin at the Mbp locus of the
myelinating cell line Olineu and of the non-myelinating line
NIH3T3, displayed a similar distribution of active and repressive
marks. While the chromatin isolated from Olineu cells was
characterized by the presence of bivalent marks, similar to
primary OPCs, the most remarkable difference between the
myelinating and non-myelinating lines was the prominence of a
repressive histone code in NIH3T3 cells, characterized by
me3K9H3 and me3K27H3 at the CR2 and promoter region of
Mbp (Figure 2D). These data suggest that distinct cell types adopt
precise histone codes to modulate the accessibility of TFs to the
chromatin regions containing myelin genes.
We then performed a similar sequence alignment for the Mag
gene and identified one conserved region in the proximal
promoter, one in the distal promoter (CR1) and two in the
transcribed region (CR2 and CR3) (Figure 3A–B). The chromatin
of undifferentiated OPCs at the CR1 and promoter regions of the
Mag locus was in a transcriptionally competent state characterized
by the bivalent mark (i.e. me3K4H3 and me3K27H3) (Figure 3C–
D). As for Mbp, the differentiation of OPCs into oligodendrocytes
was characterized by a resolution of the bivalent code also on the
Mag gene with increased me3K4H3 and decreased me3K27H3 at
the promoter and CR1 region. These modifications were specific
to myelin genes, as the histone marks did not change in the
promoter region of b-actin during OPCs differentiation (Figure S1).
Intriguingly, a comparison of the histone code of Mag in non-
myelinating NIH3T3 and myelinating Olineu cell lines, revealed
that the greatest difference was at the level of repressive mark, with
fibroblasts being characterized by the prominent presence of
me3K27H3 and me3K9H3, compared to Olineu cells (Figure 3C–
D).
From these combined data we conclude that distinctive histone
modifications at myelin gene loci modulate the accessibility of TFs
to DNA in distinct cell types. Primary OPCs and myelinating cell
lines are characterized by the presence of a transcriptionally
competent and accessible state of chromatin. Differentiation into
mature OL occurs when chromatin reorganization leads to a
transcriptionally active state characterized by the presence of
activating TFs. In non-myelinating cell lines, in contrast, the
chromatin is characterized by a repressive histone code and this
renders the myelin gene loci inaccessible to transcriptional
activation.
Treatment of fibroblasts with global epigenetic modifiers
increases the expression of myelin genes in NIH3T3 Cells
The detection of a repressive histone code at myelin gene loci in
fibroblasts suggested the possible co-existence of additional
mechanisms of epigenetic silencing, including DNA methylation
[25,26] and histone deacetylation [27,28], and prompted the
question of whether relieving such inhibition with global
epigenetic modifiers, would lead to increased expression of myelin
genes. For this reason, we treated NIH3T3 cells with the
demethylating agent 5-AzaC, the class I and II Hdac inhibitor
TSA and with the sirtuin inhibitor sirtinol either alone or in
sequential combination (i.e. 5-AzaC for 3 days followed by TSA or
sirtinol for 1 day), and then measured endogenous myelin gene
expression. Although no single treatment was effective by itself, the
combination of 5-AzaC followed by TSA was sufficient to induce
the endogenous expression of Mbp, Mag, Cnpase and Cgt in
fibroblasts, whereas treatment with 5-AzaC and sirtinol was able
to elicit this effect only for Cnpase expression (Figure 4A–D).
In addition to activating myelin gene expression, the combina-
tion 5-AzaC and TSA also caused a statistically significant increase
of the transcript levels of Olig1 (p,0.001), Olig2 (p,0.001), Mash1
(p,0.005) and Sox10 (p,0.01) and of the transcriptional inhibitor
Hes5 (p,0.001), Sox2 (p,0.001) while Id4 and Id2 were not
affected (Figure 5). Therefore the treatment of fibroblasts with
broad epigenetic modifiers up-regulated several transcripts,
although the overall pattern of gene expression did not match
the precise pattern detected in myelinating cells (Figure 1). We
have previously shown that myelin gene expression in myelinating
cells requires the down-regulation of transcriptional inhibitors [11]
and the up-regulation of transcriptional activators to levels that are
several hundred folds higher than those measured in treated
fibroblasts. We therefore reasoned that over-expression of TFs
could be necessary to impact on the amount of myelin gene
expression.
Combination of epigenetic modifiers and expression of
oligodendrocyte-specific transcription factors in
fibroblasts did not further enhance myelin gene
expression
To test the hypothesis that both the levels of transcription
factors and specific post-translational histone modifications are
necessary to achieve high levels of myelin gene expression in
fibroblasts, we combined the pharmacological manipulation of
NIH3T3 cells with chromatin modifying agents with the over-
expression of oligodendrocyte specific TFs. Fibroblasts were
treated with 5-AzaC for 3 days followed by TSA treatment for 1
day in order to remove the repressive mark and favor the
responsiveness to over-expression of Olig1, Olig2, Sox10, Mash1,
E47 and Nkx2.2. Two days later the endogenous levels of myelin
gene transcripts were quantified. Considering the previously
reported inhibitory role of Nkx2.2 on the activity of Mbp promoter
[29], we also performed the experiment in the absence of Nkx2.2.
The effect of the combined transfection and treatment on the
expression of myelin gene transcripts in fibroblasts was statistically
significant, but there was not an additive effect on the myelin gene
transcript levels (Figure 6).
Besides the obvious increase in the transcript levels of Olig1,
Olig2, Mash1, Sox10, Nkx2.2 and E47 in the transfected cells we
also detected the up-regulation of the endogenous transcriptional
Histone Code of Myelin Genes
PLoS ONE | www.plosone.org 5 September 2010 | Volume 5 | Issue 9 | e13023Figure 3. Comparison of the chromatin regions at the Mag gene between oligodendrocyte progenitors and fibroblasts. Comparative
sequence analysis of conserved (pink) and transcribed regions (blue) of the Mag promoter in different animal species (A). B, Schematic representation
of conserved and/or previously reported regulatory regions of the Mag promoter. Schematic representation of conserved regulatory regions (blue
boxes) of the Mag promoter (B). Comparative ChIP analysis of samples isolated from NIH3T3, Olineu cells (Oli), proliferating (OPC) and differentiating
(OPC diff) oligodendrocyte progenitors (C). Histone modifications in the different Mag promoter regions were assessed by chromatin
immunoprecipitation using antibodies specific for the active histone marks me3K4H3 and AcH3(C) and for the repressive histone modifications
me3K9H3 and me3K27H3 (D). The chromatin regions of the Mag gene were characterized by permissive histone marks in oligodendrocyte
progenitors and non-permissive marks in fibroblasts. ChIP was performed on five separate cultures. Results are expressed as mean 6 standard
deviation (SD) and statistically analyzed using two tailed Student’s t tests. (*p,0.05, **p,0.01).
doi:10.1371/journal.pone.0013023.g003
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recently identified TF for oligodendrocyte maturation and CNS
myelination [30]. However, despite the high levels of these
activators, the levels of myelin gene expression that were detected
in fibroblasts did not reach the levels in myelinating cells. A
potential explanation for these results was the simultaneous up-
regulation of the transcriptional inhibitors. However, qRT-PCR
measurement of the endogenous levels of Hes5, Sox2, Id4 and Id2
in 5-AzaC and TSA treated fibroblasts transfected with
oligodendrocyte-specific TFs revealed a significant increase of
Hes5 and Sox2, but not Id4 and Id2 (Figure 8). We conclude that
additional chromatin remodeling complexes, possibly coupled
with the recruitment of co-activators are necessary for the
massive induction of myelin gene expression detected in
oligodendrocytes.
Discussion
Cell identity is defined by the interplay of DNA methylation,
histone modifications microRNAs and DNA binding proteins,
which shapes the transcriptional profile of each cell type, by
modulating the chromatin landscape. The modulation of these
components has been exploited to reprogram fibroblasts into
induced pluripotent stem cells (iPS) [31]. Recently, a combination
of three defined factors (Ascl1, Brn2 and Myt1) has been identified
to be able to directly convert fibroblasts into induced neuronal (iN)
cells, indicating that the cell identity switch could occur without
going through an undifferentiated state [32].
Based on these studies, we have asked whether combinations of
oligodendrocyte-specific TFs would be able to convert fibroblasts
into myelin gene-expressing cells. However, these TFs were only
able to activate myelin gene promoter-driven luciferase reporters,
but were not sufficient to activate endogenous myelin expression
or switch cell identity. A likely explanation for the inability of
transfected TFs to generate myelin-expressing cells was the
possible existence of a repressive histone code that would
counteract the function of activating TFs. In the reprogramming
of fibroblasts into iPS or neural cells, for instance, the efficiency of
conversion is extremely low and this has been attributed to the
need for a progressive accumulation of chromatin modifications,
including changes in the histone code and in DNA marks that are
associated with switching fates [33,34]. Indeed, treatment of
fibroblasts with compounds affecting histone and DNA modifica-
tions have been used to facilitate the conversion of fibroblasts into
iPS cells [3,4,5]. Likewise, epigenetic modifications consequent to
the use of pharmacological inhibitors of histone deacetylases,
histone methyltransferases and/or DNA methyltransferases have
been reported to favor the conversion of fibroblasts into ‘‘neural-
like cells’’ [6,7].
To begin understanding the histone code that defines the
identity of an oligodendrocyte and characterizes the changes
occurring during the differentiation process, we conducted ChIP
Figure 4. Endogenous myelin gene expression in fibroblasts can be elicited by global pharmacological epigenetic modulators.
NIH3T3 cells were treated with the DNA demethylating agent, 5-azacytidine (5-AzaC), and/or with the histone deacetylases inhibitors trichostatin A
(TSA) and sirtinol. The transcript levels of Mbp (A), Mag (B), Cnpase (C) and Cgt (D) were analyzed by qRT-PCR. Endogenous myelin genes were
expressed in fibroblasts treated with 5-AzaC and TSA, but not in untreated cells, even though they did not reach the levels of myelinating cells (Olineu
cells in A and B). Also, treatment with 5-AzaC/sirtinol was less effective than 5-AzaC/TSA. Experiments were performed on three independent cultures.
Results are expressed as mean 6 standard error (SE) and statistically compared with the levels detected in untreated NIH3T3 cells using a one way
ANOVA test followed by post hoc analysis. (*p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0013023.g004
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modifications and compared the chromatin landscape at the Mbp
and Mag loci of primary OPCs differentiating into oligodendro-
cytes. We then compared these results to those obtained from
comparing the histone marks present at the same loci in
myelinating and in fibroblast cell lines. The chromatin in primary
progenitors and in myelinating cell lines was characterized by the
presence of a transcriptionally competent histone code, composed
of bivalent marks of activation (i.e. me3K4H3 and AcH3) and
repression (me3K27H3). The coexistence of functionally opposite
marks in immature progenitors and in myelinating cell lines was
indicative of a ‘‘poised’’, but inactive or weakly active transcrip-
tional state at the myelin gene loci. Differentiation into myelinat-
ing oligodendrocytes coincided with the decrease of the repressive
me3K27H3 mark and the increase of the active me3K4H3 marks
in histones at the promoter regions of Mbp and Mag. It has been
previously reported that decreased histone acetylation is part of the
activating histone codes of myelin genes, although the precise
mechanism has not yet been elucidated [16]. Our results did not
detect significant deacetylation during the transition from
progenitors to myelinating oligodendrocyte. We and others have
previously reported that histone deacetylation is a critical event for
the down-regulation of transcription factors defining the progen-
itor state [9,17]. Combined with the results of this study, we
suggest that the differentiation of progenitors into oligodendro-
cytes requires a series of sequential events and changes of histone
marks at distinct loci. Our data suggest that deacetylation of
critical lysine residues on histone H3 is an early event occurring at
loci encoding for transcriptional inhibitors of myelin genes [10,11],
and is followed by decreased repressive me3K27H3 marks and
increased activating me3K4H3 marks occurring at the loci
encoding for myelin genes. Together, these histone changes are
consistent with previous results reporting global histone deacetyla-
tion followed by histone methylation during the development of
oligodendrocytes in vivo [12].
The distinctive feature of the chromatin changes detected at
myelin gene loci in fibroblasts lines was the presence of a
repressive histone code characterized by me3K27H3 and
me3K9H3, which is consistent with the existence of a transcrip-
tionally ‘‘incompetent’’ chromatin in fibroblasts. Because tri-
Figure 6. Oligodendrocyte-specific TFs after treatment with global modifiers did not further enhance myelin gene expression.
NIH3T3 cells were treated with 5-AzaC for 3 days and TSA for 1 day and then transfected with oligodendrocyte-specific combinations of transcription
factors (Olig1, Olig2, Sox10, Mash1 , E47 with or without Nkx2.2). RNA was harvested 48 hours later and processed for qRT-PCR. Experiments were
performed in three independent cultures. Results are expressed as mean 6 standard error (SE) and statistically compared with the levels detected in
untreated NIH3T3 cells using one way ANOVA followed by post hoc analysis (*p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0013023.g006
Figure 5. Combinational treatment with epigenetic modifiers induced endogenous oligodendrocyte-specific transcription factor
expression in NIH3T3 cells. NIH3T3 cells were treated with the DNA demethylating agent 5-azacytidine (5-AzaC) and/or with the histone
deacetylase inhibitor trichostatin A (TSA) and with the sirtuin inhibitor sirtinol alone or in combination. Positive (Olig1, Olig2, Sox10 and Mash1) and
negative (Hes5, Sox2, Id4 and Id2) transcriptional regulators of myelin genes were up-regulated in NIH3T3 cells treated with 5-AzaC and TSA.
Experiments were performed in two independent cultures. Results are expressed as mean 6 standard error (SE) and statistically compared with the
levels detected in untreated 3T3 cells, using one way ANOVA followed by post hoc analysis(*p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0013023.g005
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PLoS ONE | www.plosone.org 10 September 2010 | Volume 5 | Issue 9 | e13023methylation of residue K9 on histone 3 has been previously
reported to be associated with DNA methylation [25], it was likely
that the repressive histone code in fibroblasts was associated with
DNA methylation. For this reason, we decided to treat fibroblast
lines with a pharmacological inhibitor of DNA methyltransferase
and inhibitors of histone deacetylases to overcome the ‘‘tran-
scriptionally incompetent’’ chromatin state. The detection of
endogenous myelin gene transcripts in treated fibroblasts
suggested that, even in the absence of oligodendrocyte-specific
TFs, myelin genes could be expressed. These results, however,
should be cautiously interpreted as potential reprogramming of
fibroblasts into myelin-expressing cells, because the expression of
myelin genes did not reach the levels reached in myelinating cells
and was characterized by the co-existence of transcriptional
Figure 8. Expression of positive transcriptional regulators of myelin gene expression in manipulated NIH3T3. NIH3T3 cells were
treated as described in figure 7. Experiments were performed in two independent cultures. Results are expressed as mean 6 standard error (SE) and
statistically compared with the levels detected in untreated NIH3T3 cells using two tailed Student’s t tests (*p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0013023.g008
Figure 7. Expression of positive transcriptional regulators of myelin gene expression in manipulated NIH3T3. NIH3T3 cells were
treated with 5-AzaC for 3 days and TSA for 1 day and then transfected with oligodendrocyte-specific combinations of transcription factors (Olig1,
Olig2, Sox10, Mash1, E47 and Nkx2.2). RNA was harvested 48 hours later and processed for qRT-PCR. Results are expressed as mean 6 standard error
(SE) and statistically compared with the levels detected in untreated NIH3T3 cells using two tailed Student’s t test (*p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0013023.g007
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fibroblasts to oligodendrocytes, we then attempted to overcome
the activity of the transcriptional inhibitors, by over-expressing
transcriptional activators of myelin genes. This combinational
treatment was able to up-regulate several transcriptional activa-
tors, including the recently identified oligodendrocyte differenti-
ating factor Mrf [30], although the levels of myelin gene
transcripts were still consistently lower than of the levels in
myelinating cell lines.
The inability to achieve complete reprogramming of fibroblast
into myelin-expressing cells even after manipulation of critical
epigenome modifiers and transfection of oligodendrocyte-specific
TFs could be due to several reasons. One possibility is that
oligodendrocyte differentiation might require the critical expres-
sion of specific microRNAs [35,36,37] that were not included in
our study. MicroRNAs have been involved in the removal of
transcriptional inhibition. The over-expression of TFs and up-
regulation of endogenous myelin regulators was not sufficient to
induce myelin gene expression to the levels detected in
oligodendrocytes due to the insufficient removal of transcriptional
inhibition which is mediated by microRNAs. An alternative
possibility is that we did not allow enough time to allow the
fibroblasts to modify the ‘‘memory’’ of the previous cellular
identity. This might be especially true, since our study was focused
on a fibroblast cell line that has been passaged for a very long time,
rather than on freshly isolated somatic fibroblasts. Nevertheless,
the fact that myelin gene expression can be achieved, albeit at low
levels, suggests the additional possibility that the additional
involvement of SWI/SNF subunits and ATP-dependent chroma-
tin remodelers might be required.
In conclusion, our data suggests a necessary but not sufficient
role for global epigenetic modification in reprogramming
fibroblast into myelinating cells. With further investigation of
additional key events or factors necessary for this fate switch, this
cellular system could provide an important tool for the design of
new strategies aimed at cell replacement.
Materials and Methods
Cell culture and treatment
NIH3T3 fibroblast cells were grown in DMEM supplemented
with 10% fetal bovine serum, 2 mM L-glutamine, 1 mM sodium
pyruvate, 100 U/ml penicillin, and 100 g/ml streptomycin. The
mouse oligodendrocyte precursor cell line Olineu [20] were grown
on poly-ornithine-coated culture dishes. The immature Olineu cells
were maintained in growth medium consisting of DMEM
supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate,
10 ng/ml biotin, 100 mg/ml apotransferrin, 100 mM putrescine,
20 nM progesterone, 30 nM sodium selenite, 5 mg/ml insulin, 1%
horse serum, 100 U/ml penicillin, and 100 mg/ml streptomycin.
Differentiation was induced by switching the cells to a serum-free
medium containing 1 mM dibutyril-cAMP (Calbiochem), as
described previously [20]. During the experiments where NIH3T3
cells were exposed to epigenetic modifying agents, cells were
treated with 5mM 5-Aza-29-deoxycytidine (Sigma), 10ng/ml
trichostatin A (Sigma), and 20mM sirtinol (Sigma) respectively.
NIH3T3 cells were transfected with HA-tagged Olig1, Flagged-
tagged Olig2 constructs inserted into pcDNA3.1, c-MYC-tagged
Nkx2.2 construct inserted into pcDNA3.1B, Sox10, Mash1, and E47
full-length coding sequences that were inserted into pcDNA3.1 as
previously described [18] using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol.
Oligodendrocyte progenitors were isolated from the cortex of
postnatal day 1 rats and grown for one week as mixed glial cultures
as described previously [38]. Differential shaking followed by
magnetic beads immunoselection was used to isolate progenitors.
Briefly, cells were incubated with the A2B5 antibody, and purified
using magnetic beads (Miltenyi Biotec, Auburn, CA) and then
plated at a density of 2610
5 cells/ml on poly-D-lysine coated
10 cm plates. Progenitors were maintained proliferating by the
addition of bFGF and PDGF (10 ng/ml) to the culture me-
dium (DMEM, 100 mg/ml albumin, 100 mg/ml apo-transferrin,
16 mg/ml putrescine, 0.06 ng/ml progesterone, 40 ng/ml seleni-
Table 1. Primers used in quantitative PCR for amplification of mouse gene transcript.
Gene Forward Reverse
Cgt TGGTTGACATACTGGATCACTATACT CGATCACAAATCCACACATATCATT
Cnpase TGGTGTCCGCTGATGCTTAC CCGCTCGTGGTTGGTATCAT
E47 CACTGACCACGAGCTTCACC AGGAGTCGGGAGGTCTCTGT
Gapdh ACCCAGAAGACTGTGGATGG CACATTGGGGGTAGGAACAC
Hes5 AGCAGCATAGAGCAGCTGAA TAGTCCTGGTGCAGGCTCTT
Id2 GGACATCAGCATCCTGTCCT CTCCTGGTGAAATGGCTGAT
Id4 CTGTCACCCTGCTTGTTCAC GAGACTCACCCTGCTTTGCT
Mash1 GACGCTCTTGCTCCAGGAAA CGAGAAGAGTGACTGGTGTCTGA
Mbp ACACACGACAACTACCCATTATGG AGAAATGGACTACTGGGTTTTCATCT
Mag GGTGTTGAGGGAGGCAGTTG CGTTCTCTGCTAGGCAAGCA
Mrf TGGCAACTTCACCTACCACA TGGCAACTTCACCTACCACA
Nkx2.2 ACACAGGTCAAGATCTGGTTCCA GCGTCACCTCCATACCTTTCTC
Olig1 CGACGCCAAAGAGGAACAG GCCAAGTTCAGGTCCTGCAT
Olig2 CCGAAGCAATGGGAGCAT GGAGTGTTCAGCCAAAGAGTCA
Plp CCCACCCCTATCCGCTAGTT CAGGAAAAAAAGCACCATTGTG
Sox2 AACTTTTGTCCGAGACCGAGAA CCTCCGGGAAGCGTGTACT
Sox10 GGAGATCAGCCACGAGGTAATG GTTGGGTGGCAGGTATTGGT
doi:10.1371/journal.pone.0013023.t001
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100 units/ml penicillin, 100 mg/ml streptomycin). Differentiation
was initiated by placing the cells in mitogen-free chemically
defined cultured medium, whose composition is described above.
For differentiating progenitors the treatment was performed in
proliferating conditions and during 5 days of differentiation.
Alignment of genomic sequences
Sequences and annotation used in the alignments were retrieved
using NCSRS software [21]. This web based program returns the
sequence of the upstream non-coding region, gene, and down-
stream non-coding region along with the associated annotation for
any gene (References: NCSRS - PMID: 17362514 LAGAN -
PMID: 12654723). It can also retrieve the corresponding
sequences and annotations for the set of homologs of that gene.
Select sequences and annotations are aligned with LAGAN using
the translated anchoring option.
Non-coding regions that are conserved over multiple species are
predicted to possess regulatory function. If these regions are within
1kb of a transcription start site then they are designated as
promoters. Alignments show exon regions in blue (Figure 2A and
3A). Conserved regions have a sequence similarity of a minimum
of 75% with the corresponding rat sequence for at least 100 base
pairs and are shown in pink (Figure 2A and 3A). The limits of the
conserved regions are taken to be as inclusive as possible without
losing resolution. The limits of the conserved regions for many of
the alignments tend to fall within those of the human / rat
alignment. Therefore as a general rule the limits of the human /
rat alignment are used to define the limits of the conserved regions.
Quantitative RT-PCR
Olineu, NIH3T3 or rat primary cells were homogenized in
Trizol Reagent and RNA was isolated following manufacturer’s
instruction and cleaned using RNeasy Mini kit (Qiagen,
Hilden, Germany). 2mg of total RNA was used in 20 mlo f
reverse transcription (RT) reaction, using SuperScript RT-
PCR kit (Invitrogen). Quantitative real time PCR was
performed using SYBR green PCR master mix (Applied
Biosystems, CA) in 7900HT Sequence Detection PCR System
(Applied Biosystems, CA). Melting curve of each sample was
measured to ensure the specificity of the products. Data were
normalized to the internal control Gapdh a n da n a l y z e du s i n g
Pfaffl DDCt method [39]. The primers used for amplification
are listed in Table 1 for murine transcripts and Table 2 for rat
transcripts.
Chromatin immunoprecipitation
Chromatin was isolated from OPCs and from cells maintained
in differentiation medium for 5 days. In brief, 4610
6 OPCs were
trypsinized and cross-linked with 1% formaldehyde in suspension
for 10 minutes and stopped with 0.125M glycine for 5 minutes.
Chromatin was isolated with SDS lysis buffer and fragmented by
sonication (6 cycles of 20 seconds at power level 6 in a Branson
Sonifier 450). The size of the DNA in the sheared chromatin
fragments was tested prior to precipitation, by performing agarose-
gel electrophoresis to ensure that the majority of fragment size was
300–500bp. Immunoprecipitation was performed with 2.4 mgo f
anti-me3K4H3 (Abcam, ab8580), anti-me3K9H3 (Abcam,
ab8898), anti-me3K27H3 (Upstate Biotechnology, 07-499) and
anti-AcH3 (Abcam, ab8580) antibodies previously incubated with
Protein A-coated paramagnetics beads (Invitrogen). The immu-
noprecipitated chromatin was reversed cross-linked, digested with
proteinase K and DNA was extracted by phenol-chloroform.
Immunoprecipitated samples were dissolved in 200 mL of TE and
5 mL were subjected to quantitative PCR amplification using the
primers listed in Tables 3 and 4.
The DNA recovered from chromatin which was not immuno-
precipitated (input) was used as a control for loading. Chromatin
that was immunoprecipitated with protein A-agarose in the
absence of primary antibody (no Ab) was used as a negative
control.
Table 2. Primers used in quantitative PCR for amplification of
transcripts in rat primary cultures.
Gene Forward Reverse
18s rRNA AGTCCCTGCCCTTTGTACACA GATCCGAGGGCCTCACTAAAC
Mag GCTGGGAGGGAAATACTATTTCC GACGCTGTGCTCTGAGAAGGT
Mbp AAATCGGCTCACAAGGGATTC CTCCCAGCTTAAAGATTTTGGAAA
Mog GACGCACAGAGCTTCTGAAAGA GAGAACCTCACGTTCTGGATCCT
doi:10.1371/journal.pone.0013023.t002
Table 3. Primers used for ChIP of mouse chromatin samples.
Gene
Region
(nt) Forward Reverse
Mag Promoter GCCTGGAGCTTTCAG
AAAGATGA
CTGGGACTGGGCAGCTTGAT
Mag CR1 CCTATTCACCCTCAAAGTCCA TTTCCCAGTCTGAGACAATGG
Mbp Promoter TTCAAGACCCCAGGAAGAAA TTCTTTGGGTCTGCTGTGTG
Mbp CR2 GTGGGTGGGTTGACAAGATT GAGGGCACAGGAAACAAAAA
doi:10.1371/journal.pone.0013023.t003
Table 4. Primers used for ChIP of rat chromatin samples.
Gene Region (nt) Forward Reverse
Mag Promoter CTCCTCCCCTTCCTCCATTAA GACAACAGGTTCCACCTTTCAAC
Mag CR1 CGGGCTTCATGATGTCAGACT CCCACTTTCAATGAACCATTGTC
Mbp Promoter TTCAAGACCCCAGGAAGAAA TTCTTTGGGTCTGCTGTGTG
Mbp CR1 GCAGCCACATGCCTCTCATA GGAACAAAAAGGCCCATGGT
Mbp CR2 GGCCTCTCTGTATCTCACAAATAACTG CAAAACACAAGCACATCTGAATACTAAT
betaactin promoter CGCTGTGGCGTCCTATAAAA CGAGGTAGTGGCCAAGGTAA
doi:10.1371/journal.pone.0013023.t004
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Results are expressed as mean 6 standard deviation (SD) and
statistically analyzed using two tailed Student’s t tests or one way
ANOVA followed by Dunnett’s test. A value of p,0.05 was
considered statistically significant. *p,0.05, **p,0.01, ***p,0.001.
Supporting Information
Figure S1 The pattern of histone code on the bactin gene was
similar during oligodendrocyte progenitor differentiation. The
pattern of histone modifications in beta-actin proximal promoters
was analyzed in proliferating (OPC) and differentiating (OPC diff)
rat primary oligodendrocyte cultures. Note that the histone code of
this constitutively expressed gene was similar at the two stages of
differentiation.
Found at: doi:10.1371/journal.pone.0013023.s001 (0.31 MB TIF)
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